Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Stoessl

Showing results (11-20 of 102) with videos related to

Pageof 11
Sort By:
Brain Research|September 6, 1991
Neurotensin and neurotensin analogues modify the effects of chronic neuroleptic administration in the ratA J Stoessl, E Szczutkowski
Neuropharmacology|June 1, 1993
Neuroleptic-induced chewing movements in the rat are suppressed by peripherally but not centrally administered CCK and abolished by bilateral subdiaphragmatic vagotomyA J Stoessl, E Polanski
Synapse (New York, N.Y.)|November 1, 1996
Effects of subthalamic nucleus lesions in a putative model of tardive dyskinesia in the ratA J Stoessl, N Rajakumar
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 19, 1999
Differential diagnosis of parkinsonismA J Stoessl, J Rivest
Neuroscience|June 5, 2002
Somatostatin modulates the behavioral effects of dopamine receptor activation in parkinsonian ratsJ Q Lu, A J Stoessl
Advances in Neurology|January 1, 1987
Transmitter receptor alterations in Parkinson's diseaseD B Calne, A J Stoessl
Brain Research|November 26, 1990
Autoradiographic visualization of NK-3 tachykinin binding sites in the rat brain, utilizing [3H]senktideA J Stoessl, D R Hill
Neuropharmacology|March 28, 1998
The effects of CCK-4 on dopamine D1 agonist-induced grooming are blocked by a CCK(A) receptor antagonist: evidence for a novel CCK receptor subtype?J van Kampen, A J Stoessl
Neuroscience|June 29, 2002
Blockade of nigral and pallidal opioid receptors suppresses vacuous chewing movements in a rodent model of tardive dyskinesiaS E McCormick, A J Stoessl
Neuroscience|May 29, 2003
Central administration of the neurotensin receptor antagonist SR48692 attenuates vacuous chewing movements in a rodent model of tardive dyskinesiaS E McCormick, A J Stoessl
Pageof 11

Showing results (11-20 of 102) with videos related to

Sort By:
Pageof 11
Brain Research|September 6, 1991
Neurotensin and neurotensin analogues modify the effects of chronic neuroleptic administration in the ratA J Stoessl, E Szczutkowski
Neuropharmacology|June 1, 1993
Neuroleptic-induced chewing movements in the rat are suppressed by peripherally but not centrally administered CCK and abolished by bilateral subdiaphragmatic vagotomyA J Stoessl, E Polanski
Synapse (New York, N.Y.)|November 1, 1996
Effects of subthalamic nucleus lesions in a putative model of tardive dyskinesia in the ratA J Stoessl, N Rajakumar
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 19, 1999
Differential diagnosis of parkinsonismA J Stoessl, J Rivest
Neuroscience|June 5, 2002
Somatostatin modulates the behavioral effects of dopamine receptor activation in parkinsonian ratsJ Q Lu, A J Stoessl
Advances in Neurology|January 1, 1987
Transmitter receptor alterations in Parkinson's diseaseD B Calne, A J Stoessl
Brain Research|November 26, 1990
Autoradiographic visualization of NK-3 tachykinin binding sites in the rat brain, utilizing [3H]senktideA J Stoessl, D R Hill
Neuropharmacology|March 28, 1998
The effects of CCK-4 on dopamine D1 agonist-induced grooming are blocked by a CCK(A) receptor antagonist: evidence for a novel CCK receptor subtype?J van Kampen, A J Stoessl
Neuroscience|June 29, 2002
Blockade of nigral and pallidal opioid receptors suppresses vacuous chewing movements in a rodent model of tardive dyskinesiaS E McCormick, A J Stoessl
Neuroscience|May 29, 2003
Central administration of the neurotensin receptor antagonist SR48692 attenuates vacuous chewing movements in a rodent model of tardive dyskinesiaS E McCormick, A J Stoessl
Pageof 11